SB0033: A BILL FOR AN ACT to amend the Indiana Code concerning trade regulation.

Page last updated: Friday, June 6, 2025 at 9:22 AM (America/Indianapolis).

General Information

• Stage: Senate Bill (H)
• Current Chamber: house
• Origin Chamber: senate
• Description: Consumer genetic testing providers.

Legislators

Actions (14 total)

• Mar 13, 2025, 8:03 AM: Representative Cash added as cosponsor
• Mar 3, 2025, 11:30 AM: First reading: referred to Committee on Commerce, Small Business and Economic Development
• Feb 12, 2025, 11:14 AM: Referred to the House
• Feb 11, 2025, 9:19 AM: Cosponsor: Representative Moed and Miller K
• Feb 11, 2025, 9:19 AM: House sponsor: Representative Pierce K
• Feb 11, 2025, 9:16 AM: Third reading: passed; Roll Call 96: yeas 47, nays 2
• Feb 10, 2025, 9:38 AM: Second reading: ordered engrossed
• Feb 6, 2025, 1:22 PM: Senator Koch added as coauthor
• Feb 6, 2025, 8:37 AM: Committee report: do pass, adopted
• Jan 14, 2025, 8:57 AM: Senators Ford J.D. and Spencer added as coauthors
• Jan 14, 2025, 8:57 AM: Senator Johnson T added as third author
• Jan 14, 2025, 8:57 AM: Senator Buchanan added as second author
• Jan 8, 2025, 6:49 AM: First reading: referred to Committee on Commerce and Technology
• Jan 8, 2025, 6:49 AM: Authored by Senator Hunley

Digest

Provides that a person may not discriminate against an individual on the basis of the individual's solicitation and use of consumer genetic testing services or on the basis of the results of genetic testing performed by a provider of consumer genetic testing services (provider). Requires a provider to disclose specified information to an individual who submits biological material to the provider for genetic testing. Prohibits a provider that performs, or causes to be performed, genetic testing on an individual's biological material from: (1) taking specified actions with regard to: (A) the biological material; or (B) data resulting from genetic testing performed on the biological material; unless the provider has solicited and received the individual's consent to the action; or (2) providing data, other than deidentified data, resulting from genetic testing performed on the individual's biological material to: (A) an insurer; (B) a business that provides information or data to insurers for the purposes of underwriting or rating of risks; or (C) the individual's employer. Imposes requirements on a provider with respect to: (1) controlling access to an individual's biological material and data; (2) complying with the individual's revocation of consent with regard to the individual's biological material and data; and (3) marketing or advertising sent to the individual as a result of the individual's solicitation and use of the provider's genetic testing services or use of a website or other remote or virtual service associated with the provider's genetic testing services. Provides that a provider may not charge a fee for the provision of biological material or data resulting from genetic testing performed on biological material: (1) to a law enforcement agency on the basis of a search warrant; or (2) as required by a court order; that is more than the provider's actual cost of providing the material or data. Provides for enforcement of the bill's provisions by the attorney general.